CURRICULUM VITAE

Academic qualifications:

Foreign languages and computer use:

Medical Service:

25/11/2010-25/11/2011: Military service in Greek Navy as a General Practitioner

24/4/2012-23/4/2013: Rural doctor in Amaliada General Hospital, Simopoulo Health Center, Medical office of Lampeia

24/4/2013 -25/12/2015: Registrar in Internal Medicine, Department of Internal Medicine, “A. Fleming” General Hospital, Melissia, Athens

2/11/2016-1/11/2019: Registrar in Medical Oncology, Department of Clinical Therapeutics, General Hospital Alexandra

1/04/2019-1/11/2019: Clinical rotation to General Oncology Department, UZ Leuven, Belgium

18/12/2023-today: Consultant B’, Oncology Unit, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

10/02/2021-17/12/2023: Locum Consultant, Oncology Unit, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

1/3/2020-10/2/2021: Medical Oncologist, Scientific Associate, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

10/02/2021-17/12/2023: Locum Consultant, Oncology Unit, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

18/12/2023-25/2/2024: Consultant B’, Oncology Unit, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

26/2/2024- today: Assistant Professor of Medical Oncology, Oncology Unit, 2^nd Propaedeutic Department of Medicine, 1, Rimini Street, 12462, Chaidari, Greece

Continuous Medical Education

2013 January: ACLS course

2017 October: GCP training completion

Publications:

1. Real World Data from Patients With Osteosarcoma Treated in 8 Medical Centers in Greece: Ninety Percent or Greater Tumor Necrosis Is Associated With Disease-free Survival. Kyriazoglou A, Moutafi M, Kotsantis I, Kokkali S, Antonopoulou P, Ardavanis G, Magkou E, Georgaki E, Anastasiou M, Pantazopoulos A, Boulouta A, Kyrkasiadou M, Gavrielatou N, Zazas E, Economopoulou P, Ardavanis A, Kontogeorgakos V, Lakiotaki E, Korkolopoulou P, Papagelopoulos PJ, Psyrri A, Boukovinas I.Cancer Diagn Progn. 2025 Oct 30;5(6):833-843. doi: 10.21873/cdp.10498. eCollection 2025 Nov-Dec.PMID: 41179314Free PMC article.
2. Advances in Prevention, Screening, and Early Detection of HPV-Associated Head and Neck Cancers. Zazas E, Economopoulou P, Kotsantis I, Kyriazoglou A, Samaras MG, Foukas P, Psyrri A. 2025 Oct 5;17(10):1339. doi: 10.3390/v17101339.PMID: 41157610Free PMC article. Review.
3. Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review. Serrano C, Bauer S, Blay JY, Casali PG, Cicala CM, Dei Tos AP, Digklia A, Gelderblom H, Italiano A, Jones RL, Kasper B, Kyriazoglou A, Le Loarer F, Martín-Broto J, Napolitano A, Rutkowski P, Stacchiotti S, Tap W, Thomas D, Thway K, Valverde C, van der Graaf WTA, Wardelmann E, Bovée JVMG.JAMA Oncol. 2025 Oct 16. doi: 10.1001/jamaoncol.2025.3608. Online ahead of print.PMID: 41100097
4. Artificial Intelligence in the Diagnosis and Treatment of Brain Gliomas.Evangelou K, Kotsantis I, Kalyvas A, Kyriazoglou A, Economopoulou P, Velonakis G, Gavra M, Psyrri A, Boviatsis EJ, Stavrinou LC. 2025 Sep 17;13(9):2285. doi: 10.3390/biomedicines13092285.PMID: 41007844Free PMC article. Review.
5. Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe. Kyriazoglou A, Zając A, Valverde C, Czarnecka AM, Błoński P, Romagosa C, Seliga KA, Koulouridi A, Mala A, Wągrodzki M, Silva TM, Witczak M, Ługowska I, Rosińska M, Álvarez R, Aguirre M, Tysarowski A, Kokkali S, Georgoulias V, Serrano C, Rutkowski P, Boukovinas I.ESMO Open. 2025 Sep;10(9):105577. doi: 10.1016/j.esmoop.2025.105577. Epub 2025 Sep 11.PMID: 40939238Free article.
6. The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinoma. Economopoulou P, Rampias T, Spathis A, Kotsantis I, Kyriazoglou A, Anastasiou M, Pantazopoulos A, Gomatou G, Margeli A, Papageorgiou M, Foukas P, Psyrri A.ESMO Open. 2025 Aug;10(8):105538. doi: 10.1016/j.esmoop.2025.105538. Epub 2025 Aug 12.PMID: 40803018Free PMC article.
7. Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience. Chlorogiannis DD, Kotsantis I, Economopoulou P, Kyriazoglou A, Spiliopoulos S, Kelekis N, Filippiadis DK.Cardiovasc Intervent Radiol. 2025 Aug 5. doi: 10.1007/s00270-025-04142-3. Online ahead of print.PMID: 40764465
8. Deciphering Atypical Signals Present in Fluorescent In Situ Hybridization Assays in the Diagnosis of Soft Tissue Sarcomas. Papakosta AB, Mahaira LG, Dimitriadis ES, Rizou HN, Kyriazoglou AI, Stefanaki K, Papadakis V, Kattamis A, Anthouli FA. 2025 Jun 26;17(6):e86795. doi: 10.7759/cureus.86795. eCollection 2025 Jun.PMID: 40718211Free PMC article.
9. Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions. Kokkali S, Dolcan A, Boye K, Kyriazoglou A, Boukovinas I, Kalofonou F, Koumarianou A, Asimakopoulou N, Vorrias E, Tsapakidis K, Georgaki E, Boulouta A, Mavroeidis L, Harneshaug M, Theocharis S, Jones RL, Digklia A.Acta Oncol. 2025 Jun 10;64:761-768. doi: 10.2340/1651-226X.2025.43135.PMID: 40495323Free PMC article.
10. Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma. Papanikolaou C, Economopoulou P, Spathis A, Kotsantis I, Gavrielatou N, Anastasiou M, Moutafi M, Kyriazoglou A, Foukas GP, Lelegiannis IM, Rimm D, Panayiotides I, Foukas P, Souliotis VL, Psyrri A.Br J Cancer. 2025 Aug;133(3):353-364. doi: 10.1038/s41416-025-03032-2. Epub 2025 May 23.PMID: 40410274Clinical Trial.
11. Precision Treatment of Pulmonary Sarcoma Metastasis Using Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy: A Case Report. Stergioula A, Kormas T, Kokkali S, Kyriazoglou A, Pantelis E. 2025 Apr 11;17(4):e82084. doi: 10.7759/cureus.82084. eCollection 2025 Apr.PMID: 40352030Free PMC article.
12. Ewing sarcoma of the rib with a rare PTEN mutation. Fallon P, Boulouta A, Papacharalambous C, Kyriazoglou A, Vlachostergios PJ.Cancer Genet. 2025 Jun;294-295:90-93. doi: 10.1016/j.cancergen.2025.04.003. Epub 2025 Apr 12.PMID: 40245483
13. Wound Healing Complications after Neoadjuvant Radiotherapy Combined with Targeted Therapies in Soft Tissue Sarcoma Patients. Georgopoulos NS, Tolia M, Boulouta A, Kyriazoglou A, Patriarcheas V, Dimakakos E, Schizas D, Mauri D, Tsoukalas N, Chalampakis N, De Mello RA, Antoniadis C, de Bree E, Michelakis D, Tsapakidis K, Mazonakis M, Kountourakis P, Nixon I, Mavroudis D, Gkantaifi A.Rev Recent Clin Trials. 2025 Mar 28. doi: 10.2174/0115748871354960250315170817. Online ahead of print.PMID: 40176686
14. Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S; API-CAT Investigators.N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29.PMID: 40162636Clinical Trial.
15. Harlequin syndrome in a young patient with osteosarcoma after pleural metastasectomy: A case report and a mini review of the literature. Moutafi M, Kyriazoglou A, Kotsantis I, Economopoulou P, Efthymiou E, Kyrkasiadou M, Boulouta A, Gavrielatou N, Zazas E, Markakis K, Psyrri A.Exp Ther Med. 2025 Jan 30;29(4):62. doi: 10.3892/etm.2025.12812. eCollection 2025 Apr.PMID: 39991718Free PMC article.
16. Primary and Metastatic Pancreatic Ewing Sarcomas: A Case Report and Review of the Literature. Koufopoulos NI, Samaras MG, Kotanidis C, Skarentzos K, Pouliakis A, Boutas I, Kontogeorgi A, Zanelli M, Palicelli A, Zizzo M, Broggi G, Caltabiano R, Kyriazoglou AI, Goutas D.Diagnostics (Basel). 2024 Nov 29;14(23):2694. doi: 10.3390/diagnostics14232694.PMID: 39682601Free PMC article.
17. Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review. Boulouta A, Kyriazoglou A, Kotsantis I, Economopoulou P, Anastasiou M, Pantazopoulos A, Kyrkasiadou M, Moutafi M, Gavrielatou N, Zazas E, Caglar C, Nixon I, Tolia M, Kavourakis G, Psyrri A.Cancer Treat Rev. 2024 Nov;130:102820. doi: 10.1016/j.ctrv.2024.102820. Epub 2024 Aug 24.PMID: 39216184Free article.
18. Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study. Liontos M, Bournakis E, Bournakis A, Kostouros E, Zolota V, Papatheodoridi AP, Karalis K, Kyriazoglou A, Zakopoulou R, Vasili E, Tzovaras A, Dimitriadis I, Emmanouil G, Mauri D, Christodoulou C, Tsiatas M, Zagouri F, Bamias A.Clin Genitourin Cancer. 2024 Dec;22(6):102170. doi: 10.1016/j.clgc.2024.102170. Epub 2024 Jul 26.PMID: 39191062Free article.
19. Implications of the Hippo Pathway Dysregulation in Uterine Leiomyosarcoma. Kyriazoglou A, Papachristou DJ, Moutafi M, Papakosta A, Papatheodoridi A, Kaparelou M, Korakiti AM, Liontos M, Dimopoulos MA, Zagouri F.Anticancer Res. 2024 Aug;44(8):3331-3336. doi: 10.21873/anticanres.17152.PMID: 39060085
20. The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers. Kokkali S, Boukovinas I, de Bree E, Koumarianou A, Georgoulias V, Kyriazoglou A, Tsoukalas N, Memos N, Papanastassiou J, Stergioula A, Tsapakidis K, Loga K, Duran-Moreno J, Papanastasopoulos P, Vassos N, Kontogeorgakos V, Athanasiadis I, Mahaira L, Dimitriadis E, Papachristou DJ, Agrogiannis G.Cancers (Basel). 2024 Jun 24;16(13):2314. doi: 10.3390/cancers16132314.PMID: 39001377Free PMC article.
21. Expression of DNA Repair Genes in Ewing Sarcoma. Kyriazoglou A, Moutafi M, Zografos E, Konteles V, Sofianidis G, Mahaira L, Papakosta A, Tourkantoni N, Patereli A, Stefanaki K, Tzotzola V, Mpaka M, Polychronopoulou S, Dimitriadis E, Kattamis A.Cancer Diagn Progn. 2024 May 3;4(3):231-238. doi: 10.21873/cdp.10313. eCollection 2024 May-Jun.PMID: 38707718Free PMC article.
22. Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms. Kyriazoglou A, Pagkali A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Moutafi M, Gavrielatou N, Anastasiou M, Boulouta A, Pantazopoulos A, Giannakakou M, Digklia A, Psyrri A.Cancer Treat Rev. 2024 Apr;125:102716. doi: 10.1016/j.ctrv.2024.102716. Epub 2024 Mar 11.PMID: 38492514
23. Anastasiou M, Kyriazoglou A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Giannopoulou A, Kosmidou A, Smerdi D, Moutafi M, Gavrielatou N, Psyrri A. Immune checkpoint inhibitors in sarcomas: a systematic review. Immunooncol Technol. 2023 Sep 28;20:100407. doi: 10.1016/j.iotech.2023.100407. eCollection 2023 Dec.PMID: 38192615 Free PMC article.
24. Economopoulou P, Spathis A, Kotsantis I, Maratou E, Anastasiou M, Moutafi MK, Kirkasiadou M, Pantazopoulos A, Giannakakou M, Edelstein DL, Sloane H, Fredebohm J, Jones FS, Kyriazoglou A, Gavrielatou N, Foukas P, Panayiotides I, Psyrri A. Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC). Oral Oncol. 2023 Mar 3;139:106358. doi: 10.1016/j.oraloncology.2023.106358. Online ahead of print. PMID: 36871349
25. Tolia M, Gkantaifi A, Hayward L, Gupta G, Kyriazoglou A, Mauri D, Nixon I Superficial soft tissue sarcomas: 10‑year survival outcomes. Oncol Lett. 2023 Jan 27;25(3):96. doi: 10.3892/ol.2023.13682. eCollection 2023 Mar. PMID: 36817037Free PMC article.
26. Wetterwald L, Riggi N, Kyriazoglou A, Dei Tos G, Dei Tos A, Digklia A.Clear cell sarcoma: state-of-the art and perspectives. Expert Rev Anticancer Ther. 2023 Mar;23(3):235-242. doi: 10.1080/14737140.2023.2183846. Epub 2023 Feb 27. PMID: 36811446
27. Kokkali S, Kyriazoglou A, Mangou E, Economopoulou P, Panousieris M, Psyrri A, Ardavanis A, Vassos N, Boukovinas I Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. J Clin Med. 2023 Jan 31;12(3):1119. doi: 10.3390/jcm12031119.PMID: 36769769Free PMC article.
28. Bamias A, Zakopoulou R, Tzannis K, Sakellakis M, Koutsoukos K, Kyriazoglou A, Panagiotou A, Armylagos S, Rokas K, Gotzias D, Boulouta A, Bozionelou V, Stravodimos K, Varkarakis I, Mavroudis D, Dimopoulos Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm. Anticancer Drugs. 2023 Mar 1;34(3):413-421. doi: 10.1097/CAD.0000000000001420. Epub 2022 Nov 16. PMID: 36730619Clinical Trial.
29. Andrikopoulou A, Zografos E, Apostolidou K, Kyriazoglou A, Papatheodoridi AM, Kaparelou M, Koutsoukos K, Liontos M, Dimopoulos MA, Zagouri F Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis..Front Oncol. 2022 Dec 1;12:1030786. doi: 10.3389/fonc.2022.1030786. eCollection 2022.PMID: 36531003
30. Kyriazoglou A, Korakiti AM, Papatheodoridi AM, Apostolidou K, Nonni A, Zografos E, Bletsa G, Tsakogiannis D, Dimopoulos MA, Zagouri F Chasing Hippos: Implications of YAP1 and TAZ Expression in Pregnancy-associated Breast Cancer Tumorigenesis In Vivo. 2022 Nov-Dec;36(6):2869-2874. doi: 10.21873/invivo.13027.PMID: 36309401
31. Kyriazoglou A, Dimitriadis E, Mahaira L, Kotsantis J, Kouloulias V, Kontogeorgakos V, Psyrri A, Agrogiannis G. Myxoid spindle cell sarcoma with ETV6-NTRK3 fusion. Cancer Genet. 2022 Nov;268-269:93-96. doi: 10.1016/j.cancergen.2022.09.012. Epub 2022 Oct 2. PMID: 36274330
32. Kyriazoglou A, Gkaralea LE, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, Chatzidakis I, Kavourakis G, Economopoulou P, Nixon IF, Psyrri A. Tyrosine kinase inhibitors in sarcoma treatment. Oncol Lett. 2022 Jun;23(6):183. doi: 10.3892/ol.2022.13303. Epub 2022 Apr 21.PMID: 35527786Free PMC article.
33. Kyriazoglou A, Jespers P, Vandecavaye V, Mir O, Kasper B, Papai Z, Blay JY, Italiano A, Zaffaroni F, Litière S, Nzokirantevye A, Schöffski P. Exploratory analysis of tumor imaging in a Phase 2 trial with cabozantinib in gastrointestinal stromal tumor: lessons learned from study EORTC STBSG 1317 ‘CaboGIST’. Acta Oncol. 2022 Jun;61(6):663-668.doi:10.1080/0284186X.2022.2068967. Epub 2022 Apr28.PMID: 35481400Clinical Trial.
34. Kyriazoglou A, Kaparelou M, Goumas G, Liontos M, Zakopoulou R, Zografos E, Zygogianni A, Dimopoulos MA, Zagouri F.Breast Care (Basel). Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review. 2022 Feb;17(1):63-70. doi: 10.1159/000514860. Epub 2021 Mar 29.PMID: 35355696Free article.
35. Kaparelou M, Liontos M, Katsimbri P, Andrikopoulou A, Papatheodoridi A, Kyriazoglou A, Bamias A, Zagouri F, Dimopoulos MA. Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience. Gynecol Oncol Rep. 2022 Mar 2;40:100953. doi: 10.1016/j.gore.2022.100953. eCollection 2022 Apr.PMID: 35265745Free PMC article.
36. Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions. Economopoulou P, Pantazopoulos A, Spathis A, Kotsantis I, Kyriazoglou A, Kavourakis G, Zakopoulou R, Chatzidakis I, Anastasiou M, Prevezanou M, Resteghini C, Licitra L, Bergamini C, Colombo E, Caspani F, Denaro N, Vecchio S, Bonomo P, Cossu Rocca M, Bertolini F, Ferrari D, Psyrri A, Bossi P. Cells. 2021 Dec 23;11(1):32. doi: 10.3390/cells11010032.PMID: 35011594 Free PMC article.
37. Brain Metastases from Adult Sarcomas: A Retrospective Cohort Study from the Hellenic Group of Sarcomas and Rare Cancers (HGSRC).Kokkali S, Vini L, Stergioula A, Kyriazoglou A, Vassos N, Boukovinas I. J Clin Med. 2021 Dec 20;10(24):5978. doi: 10.3390/jcm10245978. PMID: 34945275 Free PMC article.
38. Gkantaifi A, Diamantis A, Mauri D, Nixon I, Kyriazoglou A, Baloyiannis I, Tsoukalas N, Charalampakis N, Schizas D, Cuccia F, Alongi F, de Mello RA, Iliadis G, Kamposioras K, Mazonakis M, Tolia M. Cutaneous soft tissue sarcomas: survival-related factors. Arch Dermatol Res. 2021 Jul 17. doi: 10.1007/s00403-021-02268-1. Online ahead of print. PMID: 34272971 Review.
39. Andrikopoulou A, Fiste O, Apostolidou K, Skafida E, Markellos C, Liontos M, Kyriazoglou A, Dimopoulos MA, Zagouri F. CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience. Med Sci (Basel). 2021 Jun 5;9(2):42. doi: 10.3390/medsci9020042. PMID: 34198899 Free PMC article.
40. Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA. YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways. Oncogenesis. 2021 May 4;10(5):37. doi: 10.1038/s41389-021-00327-w. PMID: 33947829 Free PMC article.
41. Gazouli I, Kyriazoglou A, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, Chatzidakis I, Kavourakis G, Economopoulou P, Kontogeorgakos V, Papagelopoulos P, Psyrri A. Systematic Review of Recurrent Osteosarcoma Systemic Therapy. Cancers. 2021; 13(8):1757. https://doi.org/10.3390/cancers13081757
42. Kyriazoglou A, Liontos M, Ntanasis-Stathopoulos I, Gavriatopoulou M. Medicine (Baltimore). The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? 2021 Apr 2;100(13):e25309. doi: 10.1097/MD.0000000000025309. PMID: 33787622 Free PMC article.
43. Kyriazoglou A, Timmermans I, De Cock L, Laenen A, Dumez H, Sinnaeve F, Wafa H, Hompes D, Van Raemdonck D, De Leyn P, Sciot R, Hauben E, Debiec-Rychter M, Vandenbempt I, Schöffski P Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients. Oncol Res Treat. 2021 Mar 23:1-8. doi: 10.1159/000515112. Online ahead of print.PMID: 33756486
44. Ntanasis-Stathopoulos I, Kyriazoglou A, Tsilimigras DI, Tzanninis IG, Liontos M, Dimopoulos MA, Gavriatopoulou M Clear cell sugar tumor of the lung; a systematic review for a rare entity. J BUON. 2021 Jan-Feb;26(1):17-32.PMID: 33721428 Free article.
45. Kyriazoglou A, Liontos M, Zakopoulou R, Kaparelou M, Tsiara A, Papatheodoridi AM, Georgakopoulou R, Zagouri F.
46. The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review. Breast Care (Basel). 2021 Feb;16(1):6-15. doi: 10.1159/000507538. Epub 2020 May 12. PMID: 33716627 Review.
47. Kyriazoglou A, Bagos P. Meta-analysis of BCOR rearranged sarcomas: challenging the therapeutic approach. Acta Oncol. 2021 Feb 25:1-6. doi: 10.1080/0284186X.2021.1890818. Online ahead of print. PMID: 33630701
48. Vallilas C, Sarantis P, Kyriazoglou A, Koustas E, Theocharis S, Papavassiliou AG, Karamouzis MV. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules. Int J Mol Sci. 2021 Jan 6;22(2):493. doi: 10.3390/ijms22020493. PMID: 33419029 Free PMC article. Review.
49. Kyriazoglou A, Beuselinck B.Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker research. Acta Clin Belg. 2020 Dec 11:1-4. doi: 10.1080/17843286.2020.1853886. Online ahead of print. PMID: 33308043
50. Kyriazoglou A, Tourkantoni N, Liontos M, Zagouri F, Mahaira L, Papakosta A, Michali D, Patereli A, Stefanaki K, Tzotzola V, Skoura E, Baka M, Polychronopoulou S, Kattamis A, Dimitriadis E.A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene. In Vivo. 2020 Sep-Oct;34(5):2947-2954. doi: 10.21873/invivo.12125. PMID: 32871837 Free PMC article.
51. Ntanasis-Stathopoulos I, Kyriazoglou A, Liontos M, A Dimopoulos M, Gavriatopoulou M. Current trends in the management and prevention of human papillomavirus (HPV) infection. J BUON. 2020 May-Jun;25(3):1281-1285. PMID: 32862567 Free article. Review.
52. Tsironis G, Liontos M,Kyriazoglou A, Koutsoukos K, Tsiara A, Kaparelou M, Zakopoulou R, Cohen A, Skafida E, Fontara S, Zagouri F, Bamias A, Dimopoulos MA. Axitinib as a third or further line of treatment in renal cancer: a single institution experience. BMC Urol. 2020 Jun 2;20(1):60. doi: 10.1186/s12894-020-00618-1.PMID: 32487200
53. Liontos M, Sotiropoulou M, Kaparelou M, Tzannis K, Tsironis G, Kyriazoglou A, Tsiara A, Zakopoulou R, Koutsoukos K, Zagouri F, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Bamias A. Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.Gynecol Oncol. 2020 Mar 12. pii: S0090-8258(20)30224-9. doi: 10.1016/j.ygyno.2020.03.008. [Epub ahead of print]
54. Kyriazoglou A, Koutsoukos K, Zagouri F, Liontos M, Dimitriadis E, Tiniakos D, Dimopoulos MA. Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising? Ther Clin Risk Manag. 2020 Feb 27;16:141-146. doi: 10.2147/TCRM.S220804. eCollection 2020
55. Eleni Zografos, Flora Zagouri, Despoina Kalapanida, Roubini Zakopoulou, Anastasios Kyriazoglou, Kleoniki Apostolidou, Maria Gazouli, Meletios-Athanasios Dimopoulos Prognostic role of microRNAs in Breast cancer: a systematic review, Oncotarget, PMID: 31903173, PMCID: PMC6935258, DOI: 10.18632/oncotarget.27327
56. Kyriazoglou A, et al. Emerging Insights Into the Role of the Hippo Pathway in Multiple Myeloma and Associated Bone Disease, Clin Lymphoma Myeloma Leuk 2019. PMID 31734019
57. Zagouri F, Korakiti AM, Zakopoulou R, Kyriazoglou A, Zografos E, Haidopoulos D, Apostolidou K, Papatheodoridi MA, Dimopoulos MA. Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis. Cancer Treat Rev. 2019 Aug 6;79:101885. doi: 10.1016/j.ctrv.2019.08.001. [Epub ahead of print] Review.PMID: 31442939
58. Anastasios Kyriazoglou, Flora Zagouri, Meletios Athanasios Dimopoulos Olaratumab administered in two cases of phyllodes tumor of the breast: end of the beginning? ESMO OPEN, 2019 Jun 25;4(3):e000479. doi: 10.1136/esmoopen-2018-000479. eCollection 2019
59. Wen-Bin Ou, Nan Ni, Rui Zuo, Weihao Zhuang, Meijun Zhu, Anastasios Kyriazoglou, Duolin Wu, Grant Eilers, George Demetri, Hai-Bo Qiu, Bin Li, Adrian Marino-Enriquez, and Jonathan Fletcher . Cyclin D1 is a Mediator of Gastrointestinal Stromal Tumor KIT-independence, Oncogene, 2019 Aug 1. doi: 10.1038/s41388-019-0894-3
60. Kyriazoglou, G.Tsironis, M.Liontos, A.Papakosta, L.Mahaira, N.Thomakos, G.Morphopoulos, I.Papaspyrou, A.Bamias Ewing’s sarcoma of the cervix: a case report of an unusual diagnosis in pregnancy treated with surgery, adjuvant VIDE and Radiotherapy, Oncology Letters, 2019 Jun;17(6):5529-5535. doi: 10.3892/ol.2019.10267. Epub 2019 Apr 18
61. Liontos M, Kyriazoglou A, Dimitriadis I, Dimopoulos MA, Bamias A. Systemic therapy in cervical cancer: 30 years in review. Crit Rev Oncol Hematol. 2019 May;137:9-17. doi: 10.1016/j.critrevonc.2019.02.009. Epub 2019 Feb 28. Review. PMID: 31014518
62. Kyriazoglou A, Zagouri F, Fotiou D, Dimitrakakis C, Marinopoulos S, Zakopoulou R, Kaparelou M, Zygogianni A, Dimopoulos MA. Discrepancies of current recommendations in breast cancer follow-up: a systematic review. Breast Cancer. 2019 Mar 18. doi: 10.1007/s12282-019-00963-6. [Epub ahead of print]PMID: 30887287
63. Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution. BMC Cancer. 2018 Dec 13;18(1):1247. doi: 10.1186/s12885-018-5156-1. PMID: 30541504 Free PMC Article
64. Kyriazoglou A, Liontos M, Papadopoulos C, Bilali A, Kostouros E, Pagoni S, Doumas K, Dimopoulos MA, Bamias A. Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature. Clin Genitourin Cancer. 2018 Dec 4. pii: S1558-7673(18)30781-X. doi: 10.1016/j.clgc.2018.11.022. [Epub ahead of print] No abstract available. PMID: 30612920
65. Tsironis G, Ziogas DC, Kyriazoglou A, Lykka M, Koutsoukos K, Bamias A, Dimopoulos MA. Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore? Ann Transl Med. 2018 Apr;6(8):143. doi: 10.21037/atm.2018.02.18. Review.
66. Kyriazoglou1 ,G.Rigakos1, A. Vernadou, S. Papadopoulos, E. Skarpidi, P.Nomikos, C. Dardoufas, G.Nassioulas, G. Kouvatseas, O. Spyri, S. Labropoulos, E.Razis. Bevacizumab in high grade glioma: is there a subgroup that benefits? DOI: 10.15761/HMO.1000131, Hematology and Medical Oncology, June 15, 2017
67. Dimitrios C. Ziogas, Michalis Liontos, Anastasios Kyriazoglou, Georgios Tsironis, Aristotelis Bamias & Meletios-Athanasios Dimopoulos Gefitinib: an “orphan” drug for non-small cell lung cancer Pages 899-906 | Received 07 Jun 2017, Accepted 12 Oct 2017, Accepted author version posted online: 13 Oct 2017, Published online: 17 Oct 2017
68. Anastasios Kyriazoglou, Ioannis Dimitriadis, Aristotelis Bamias Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease, Published Online: 2017-06-30 | DOI: https://doi.org/10.1515/fco-2015-0025
69. Kyriazoglou A, Christopoulos C. Severe dental erosion associated with imatinib mesylate therapy. Acta Oncol. 2014 Jan 21. (doi:10.3109/0284186X.2013.879999)
70. Kyriazoglou AI, Rizou H, Dimitriadis E, Arnogiannaki N, Agnantis N, Pandis N. Cytogenetic analysis of a low-grade secondary peripheral chondrosarcoma arising in synovial chondromatosis. In Vivo. 2013 Jan-Feb;27(1):57-60.
71. Kyriazoglou AI, Vieira J, Dimitriadis E, Arnogiannaki N, Teixeira MR, Pandis N. 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma. Cancer Genet. 2012 Jun;205(6):332-6.
72. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas. Cancer Genet. 2011 Dec;204(12):677-81.
73. Dimitriadis E, Rontogianni D, Kyriazoglou A, Takou A, Frangia K, Pandis N, Trangas T, Novel SYT-SSX fusion transcript variants in synovial sarcoma. Cancer Genet Cytogenet. 2009 Nov;195(1):54-8.
74. Tsarouha H, Kyriazoglou AI, Ribeiro FR, Teixeira MR, Agnantis N, Pandis N. Chromosome analysis and molecular cytogenetic investigations of an epithelioid hemangioendothelioma, Cancer Genet Cytogenet 2006 Sep;169(2):164-8

Presentations at Scientific Conferences:

2006: The practical applications of Genetics and Molecular Biology methods in the diagnosis and treatment of myoskeletal tumors, 10^th Panhellenic Congress of Orthopaedic Oncology, Kalamata, 5-6 May 2006

2009: Multi-color banding studies of a low grade chondrosarcoma arising in synovial chondromatosis, 3^rd Hellenic-Jordanian Congress of Pathology, 29-31 October, Limassol, Cyprus

2013: Genetics and molecular cytogenetics on the diagnosis of sarcomas, 69th Panhellenic Congress of Orthopaedics and Traumatology, 2-5 October, Athens, Greece, oral presentation

2017: Biomarkers: the development, Congress: «From Chemotherapy to Molecular targeting», 8-10 December 2017, Divani Caravel, Athens

2017: Young MMOF- Mentorship session, Gynecological cancer Case presentation, 5th Congress of the Mediterranean multidisciplinary oncology forum, 23-25 November, Hilton, Athens, Greece

2018: Evaluation of Chemotherapy Response Score and lymphocytic infiltration as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy, ESMO 2018 Congress Munich, Germany, poster presentation

2019: Endometrial stromal sarcomas a review, Second Masterclass of sarcomas, Greek Group of sarcomas and rare tumors, Athens, Greece 15-16 March 2019, oral presentation

2019: Clinical case presentation: young male with retroperitoneal leiomyosarcoma, 13^th Educational Seminar of Molecular Oncology and targeted therapy, 29-31 March, Ioannina, Greece, oral presentation

2019: Study of efficacy and safety of Axitinib beyond the second line in patients with metastatic renal cell carcinoma, Greek Congress of Clinical Oncology, 18-21 April 2019, Athens, Greece, poster presentation

2019: Expression analysis of NHEJ and HR genes in Ewing sarcomas: indications of DSB repair dysfunction, A.Kyriazoglou et al., ESMO 2019, Barcelona, Spain 27 September- 1 Ovtober 2019, poster session

2019: BCOR sarcomas: a case series with a new splice variant of BCOR/CCNB3 fusion gene. A.Kyriazoglou et al., CTOS 2019, Tokyo, Japan, 13-16 November 2019, poster session

2020: Nephrectomy and metastasectomy in mRCC patient in the era of Immunotherapy and Targeted therapies, Thessaloniki, 6-7 March 2020, Modern Oncology, oral presentation

Participation in international Workshops:

2006: 10^th European Workshop of Molecular Cytogenetics in Human Solid Tumors, La Grande Motte, France, 8-11 June 2006

2007: Training Workshop on mFISH and mBAND at Metasystems, Altlusheim, Germany, 12-14 September 2007

2008: 11^th European Workshop of Molecular Cytogenetics in Human Solid Tumors, Bilbao , 6-9 September 2008

2014: 23^rd AACR Workshop of Molecular Biology in Clinical Oncology, Snowmass Village, Colorando, July 20-26, 2014

2018: ESMO Preceptorship on Metastatic Bladder and Kidney Cancer – Zurich – 23-24 Nov 2018

Lab experience:

Memberships:

• Hellenic Society of Medical Oncology (HeSMO)
• European Society for Medical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)
• Chair of the Coordinating Committee of the Hellenic Group of Young Oncologists (HeGYO)
• Hellenic group of Sarcomas and Rare tumors (HGSRT)